Back to Janus Henderson Group Ltd.

FDMT
Showing 8 of 22 quarters

Position history for Janus Henderson Group Ltd.'s holdings in 4D MOLECULAR THERAPEUTICS IN

Janus Henderson Group Ltd. holds 5.2M shares of FDMT (4D MOLECULAR THERAPEUTICS IN), worth $48.9M as of 2026-Q1. The position was increased (+13.2% shares). FDMT represents 0.0% of Janus Henderson Group Ltd.'s portfolio.

Current Value

$48.9M

Current Shares

5.2M

Total Value Change

-$18.2M

Total Shares Change

+2.1M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q1
Latest
Increased
5.2M
+13.2%
$48.9M0.0%$8.46
33
2025-Q4
Increased
4.6M
+164.4%
$34.7M0.0%$7.58
47
2025-Q3
Decreased
1.8M
-0.1%
$15.2M0.0%$8.35
0
2025-Q2
Decreased
1.8M
-7.3%
$6.5M0.0%$3.84
0
2025-Q1
Decreased
1.9M
-16.0%
$6.9M0.0%$3.63
0
2024-Q4
Decreased
2.3M
-28.2%
$12.5M0.0%$5.30
0
2024-Q3
Decreased
3.1M
-1.9%
$33.9M0.0%$10.83
0
2024-Q2
Decreased
3.2M
-0.0%
$67.1M0.0%$20.99
0

Other major holders of FDMT: VIKING GLOBAL INVESTORS LP, RA CAPITAL MANAGEMENT, L.P., BlackRock Finance, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used